Dashboard
Manage Tickers

PCSA Processa Pharmaceuticals, Inc.

Nasdaq processapharmaceuticals.com


$ 0.32 $ -0.01 (-3.2 %)    

Friday, 07-Nov-2025 18:03:09 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 0.3058
$ 0.30
$ 0.27 x 5,300
$ 0.35 x 651
$ 0.28 - $ 0.32
$ 0.15 - $ 1.50
2,112,555
na
17.32M
$ 0.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-20-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-29-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-30-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 03-25-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 03-06-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-14-2019 03-31-2019 10-Q
28 03-28-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-21-2018 03-31-2018 10-Q
32 04-16-2018 12-31-2017 10-K
33 11-20-2017 09-30-2017 10-Q
34 10-04-2017 06-30-2017 10-Q
35 10-04-2017 03-31-2017 10-Q
36 09-25-2017 12-31-2016 10-K
37 09-08-2017 09-30-2016 10-Q
38 08-30-2017 06-30-2016 10-Q
39 08-07-2017 03-31-2016 10-Q
40 06-19-2017 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

processa-pharmas-abstract-adaptive-phase-23-study-for-pcs499-499-in-patients-with-focal-segmental-glomerulosclerosis-fsgs-accepted-for-presentation-at-asn-kidney-week-2025
Processa Pharma's Abstract, "Adaptive Phas...
11/05/2025 14:16:42

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 12:08:54

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 21:06:30

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/09/2025 17:06:06

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/09/2025 12:07:59

why-processa-pharmaceuticals-stock-rose-almost-38-overnight
Why Processa Pharmaceuticals Stock Rose Al...
10/08/2025 07:40:28

Processa Pharmaceuticals shares jumped 37.5% after hours following a strong regular session, despite facing significant losses ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 21:06:58

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 12:08:21

why-telomir-pharmaceuticals-shares-are-trading-higher-by-31-here-are-20-stocks-moving-premarket
Why Telomir Pharmaceuticals Shares Are Tra...
10/07/2025 09:28:45

hc-wainwright--co-maintains-buy-on-processa-pharmaceuticals-lowers-price-target-to-1
HC Wainwright & Co. Maintains Buy on Proce...
09/02/2025 11:18:25

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers th...

processa-pharma-q2-eps-025-misses-020-estimate
Processa Pharma Q2 EPS $(0.25) Misses $(0....
08/07/2025 21:54:51

Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0...

processa-pharmaceuticals-announces-an-investment-and-said-it-is-evaluating-corporate-crypto-treasury-strategies-financial-terms-not-disclosed
Processa Pharmaceuticals Announces An Inve...
08/07/2025 12:38:13

processa-pharmaceuticals-signs-binding-term-sheet-granting-intact-therapeutics-an-exclusive-option-to-license-pcs12852-strengthens-balance-sheet-with-7m-capital-infusion
Processa Pharmaceuticals Signs Binding Ter...
07/01/2025 13:19:32

Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852Continue enrolling patients in Ph...

hc-wainwright--co-maintains-buy-on-processa-pharmaceuticals-lowers-price-target-to-2
HC Wainwright & Co. Maintains Buy on Proce...
06/30/2025 10:57:56

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers th...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
06/23/2025 12:08:57

why-sequans-communications-shares-are-trading-higher-by-over-42-here-are-20-stocks-moving-premarket
Why Sequans Communications Shares Are Trad...
06/23/2025 10:51:46

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
06/20/2025 17:05:58

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/20/2025 12:09:39

why-cheetah-mobile-shares-are-trading-higher-by-over-11-here-are-20-stocks-moving-premarket
Why Cheetah Mobile Shares Are Trading High...
06/20/2025 10:01:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION